Keywords: Bristol-Myers Squibb, Ono Pharma, Orencia, Antibody, Rheumatoid arthritis, Japan

Bristol-Myers gets more rights to Ono antibody in exchange for Japan co-rights to Orencia

Article | 22 September 2011

Print This

US drug major Bristol-Myers Squibb (NYSE:BMY) says it has agreed with Japan’s Ono Pharmaceutical (TYO: 4528) to expand ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in